Kythera Biopharamaceuticals
Download our corporate fact sheet
Careers  |  Contact Us
  • Home
  • About
  • Products
  • Collaborative Partners
  • Investors
  • Newsroom
About
  • Overview
  • Values
  • Our Story
  • Our Team
  • Board of Directors
  • Company Advisors
Products
  • Overview
  • ATX-101
Newsroom
  • Press Releases
  • Media Coverage
  • Corporate Presentations

Newsroom

  • Press Releases
    • Current
    • 2011 Archive
    • 2010 Archive
    • 2009 Archive
    • 2008 Archive
    • 2007 Archive
    • 2006 Archive
  • Media Coverage »
  • Corporate Presentations »

Kythera Newsroom

2010 Archive

October 27, 2010
Kythera Appoints François Kress To Board Of Directors

September 20, 2010
Kythera Biopharmaceuticals to Present at the UBS 2010 Global Life Sciences Conference

September 20, 2010
Kythera Biopharmaceuticals Announces Proof-of-Concept Study Results for ATX-202 In Vitiligo; Plans to Continue Research Efforts In Pigmentation Disorders

August 30, 2010
Kythera and Bayer Dermatology Unit Intendis Enter Licensing and Development Agreement for Adipolytic Agent ATX-101

June 11, 2010
Kythera Biopharmaceuticals to Participate in The Private Company Forum at The 31st Annual Goldman Sachs Global Healthcare Conference

April 27, 2010
Kythera Biopharmaceuticals Appoints Industry Veteran as Vice President, Global Clinical Operations

January 8, 2010
KYTHERA Biopharmaceuticals To Present At The 28th Annual J.P. Morgan Healthcare Conference

View Pipeline »
Hide
Submental Fat Reduction »
Home | About | Products | Collaborative Partners | Investors | Newsroom | Careers | Contact Us | Site Map
© 2011 Kythera Biopharmaceuticals, Inc. | Website by RBD